ZM25

[ZM25 @ZM2514]

@MartinShkreli https://t.co/RI10tGiPp8 VRTX with Nav 1.8

[ZM25 @ZM2514]

@chaotropy @ElicioTx Your model is off

[ZM25 @ZM2514]

@Biohazard3737 Claude Fable got it in one shot a day prior...I told it to make no mistakes...

[ZM25 @ZM2514]

@SahilBloom Labeling yourself NYT bestselling author

[ZM25 @ZM2514]

@johnarnold -Former Enron employee

[ZM25 @ZM2514]

@TheBiotechBear Yes, it goes by the Dirk

[ZM25 @ZM2514]

@Anders_Research Pretty solid list of names disclosed today.

[ZM25 @ZM2514]

@Archimedes20311 @chaotropy Most proximate event is q4w China study so there's time...

[ZM25 @ZM2514]

@patrick_oshag @colossusmag @bingbingbom

[ZM25 @ZM2514]

@Anders_Research Anxiously awaiting 13Gs - preclinical data looking good, I’m sure specialists came to same conclusion that this is worth a shot.

[ZM25 @ZM2514]

@Anders_Research Are you planning to write this one up? It looks cheap here after the raise, and they have some compelling preclinical data. The phase 1b was small and noisy - looking forward to the interim in Q4.

[ZM25 @ZM2514]

@WilliamCohan @apolloglobal Congrats! I really enjoyed Four Friends.

[ZM25 @ZM2514]

@A_May_MD Assuming OX40 is dead, why are companies like $IMA getting PIPE'd https://t.co/WMebEFgZjq

[ZM25 @ZM2514]

@BiotechAutist So youre the one overpaying for the 7.5s?

[ZM25 @ZM2514]

@BioWino @MartinShkreli

[ZM25 @ZM2514]

@aditharun_ @RayneWothbaum Ask all the hospitals paying a premium to use Nymalize which is oral (just liquid formulation). It's a huge pain point - have you rotated in the neuro ICU yet or care for a SAH patient? Not sure whether we'll get a CMC CRL or whatnot but definitely a place for IV

[ZM25 @ZM2514]

@ElizabethHolmes @signulll Then who would do your lab work? Theranos?

[ZM25 @ZM2514]

@financebully @hannibalspeaks Why not start on Rinvoq and transition to Rezpeg for maintenance? @A_May_MD

[ZM25 @ZM2514]

@A_May_MD $CUE read through @Kennydoesbio

[ZM25 @ZM2514]

@Investorclimber It’s the “discuss” vs “proliferator” tea leaves